MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy
Clinical trial NCT01068587 · COMPLETED
Trial details
- NCT number
- NCT01068587
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-21
- Primary completion
- 2014-03-21
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.